Navigation Links
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
Date:11/23/2009

MINNEAPOLIS, Nov. 23 /PRNewswire/ -- BridgePoint Medical announced today that it received European CE Mark (Conformite Europeene) for its coronary and peripheral Chronic Total Occlusion (CTO) Crossing System comprised of the CrossBoss(TM) CTO Crossing Catheter and the Stingray® CTO Re-Entry System. The BridgePoint System is a series of interventional catheters that are designed to navigate highly diseased arteries in preparation for blood flow restoration via angioplasty and stenting.

The National Heart, Lung and Blood Institute (NHLBI) estimates that Chronic Total Occlusions (CTOs) are common and are found in approximately one-third of patients who undergo angiography, which equates to a world wide annual incidence of 1.3 million patients. Interventional cardiologists are currently unable to broadly treat patients with chronic total occlusions due to the procedurally challenging and advanced nature of the disease. For these patients, alternatives include bypass surgery or pharmacologic therapy. For the millions of people with living with a coronary CTO, chest pain, shortness of breath and fatigue are part of every day life.

"We have seen many attempts to implement new tools for the treatment of chronic coronary occlusions over the years, but until now none of them have provided any advantage over the current treatment of using specialty guidewires," said Gerald Werner M.D. Ph.D., Professor at the Klinikum Darmstadt in Darmstadt, Germany. "This system is the first to provide a new option for the frequent situation when our guidewires do not reach the vessel beyond the occlusion. The BridgePoint system makes it possible to find the true vessel lumen and conclude the treatment successfully."

The disposable BridgePoint Catheter System does not require the use of expensive and cumbersome capital equipment and uses techniques that are common in interventional medicine.

"The CrossBoss and Stingray devi
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
(Date:9/2/2015)... -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced that ... Company,s Board of Directors has engaged Morgan Stanley  & ... to maximize shareholder value. Potential strategic ... process may include a possible sale of the Company, ...
(Date:9/2/2015)... WORCESTER, Mass. and ... -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: ... intention to implement a buccal cannabis co-development ... ) has been formalized. Generex ... Co-Development and Technology Licensing Agreement.  Pursuant to ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2Unilife Announces Review of Strategic Alternatives 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3
... CAMDEN, N.J., July 15, 2011 IBM (NYSE: IBM ... largest biobank of living human cells, is using IBM technology ... and to more efficiently maintain its massive collection of biological ... better protect millions of genetic samples while also increasing its ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) announced ... after the market closes on Thursday, August 4, 2011.  A ... Thursday, August 4, 2011, at 5:00 p.m. Eastern Time to ... please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international ...
Cached Medicine Technology:Coriell Institute Teams With IBM to Advance Personalized Medicine 2Coriell Institute Teams With IBM to Advance Personalized Medicine 3Coriell Institute Teams With IBM to Advance Personalized Medicine 4
(Date:9/2/2015)... ... 2015 , ... The medical waste management market is expected to reach USD ... 5.2%. The global medical waste management market is segmented based on type of waste, ... to register the highest growth rate in the medical waste management market, by service, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding ... actress as the primary love interest in the film. The campaign is being called ... affects how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... food banks in commemorating “Hunger Action Month” during the entire month of September. ... Food Bank will be dedicating its efforts this September to an awareness campaign ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... companies, has completed a recapitalization with new investment partners Beecken Petty O’Keefe ... Group each offer extensive expertise and connections within the healthcare industry, which ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4
... North America -, PRINCETON, N.J., Dec. 18 ... Barr has been named Covance,s Chief,Operating Officer, effective ... of Early Development North America, will assume operating,responsibility ... to,Joe Herring, Covance,s Chairman and Chief Executive Officer. ...
... slightly more effective than traditional lung scans, , , TUESDAY, ... a life-threatening blood clot in the lungs -- can ... a technique using CT scanning might be slightly more ... Canadian researchers found that computed tomographic pulmonary angiography (CTPA) ...
... team of researchers led by Mayo Clinic have designed a ... to destroy cancer cells that spread from primary tumors to ... addition, their study shows that this technology could be the ... , The study appeared in the Dec. 9 online issue ...
... screenings for those with severe illnesses, they may bring ... a recent study by Yale School of Medicine researchers ... study offers a new approach for assessing who is ... recommendations can be tailored more effectively to individual patients. ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... and hospitals throughout the United States,today announced that ... Healthcare,Conference, January 10, 2008, at 8:30 a.m. PST ... Paul Berger, Chairman and CEO, Tim Mayleben, President,and ...
... Dec. 18 Psoriasis Cure Now,a nonprofit patient ... an association between severe psoriasis and a significantly,increased ... psoriasis research. The,study, by a team of University ... severe psoriasis have a 50 percent,increased risk of ...
Cached Medicine News:Health News:Wendel Barr Appointed Chief Operating Officer of Covance 2Health News:Wendel Barr Appointed Chief Operating Officer of Covance 3Health News:CT Scans Catch More Clots in Lungs 2Health News:CT Scans Catch More Clots in Lungs 3Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Colon cancer screenings may not pay off and could pose harm to some 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: